⋮
0
0
武田研究中的用于复发或难治全身性轻链淀粉样变的口服蛋白酶体抑制剂Ixazomib被美国FDA认定为突破性治疗药物
Showing live article 530 of 5564 in channel 19681001
Article Details:
Author:
Language: Japanese
Channel Number: 19681001
Article Number: 530
Date: December 1, 2014, 9:00 pm
URL: http://www.qlifepro.com/press/20141202-23-16782/ma-takeda-pharmaceutical-3/
GUID: http://www.qlifepro.com/press/?p=16782
←
$
..going to article 530
X
X
NSFW?
Claim
0
X
Mark channel Not-Safe-For-Work?
cancel
confirm
NSFW Votes:
(
0
votes)
X
Are you the publisher?
Claim
or
contact us about
this channel.
X
No ratings yet.
X
RSSing.com
Search
Sharing:
Title:
URL:
Copy Share URL